Press Room

For Media Inquiries:

Contact Julie Livingston julie@medshadow.org | 347-239-0249

Press Releases:

Suzanne Robotti, President, MedShadow Foundation, Named to FDA Drug Safety and Risk Management Advisory Committee

February 14, 2017, New York, NY – The Food and Drug Administration (FDA) has named Suzanne Robotti, founder and president of MedShadow Foundation, to its Drug Safety and Risk Management Advisory Committee as the Consumer Representative. Next month, she will attend her first hearing where a prescription opioid drug will Continue Reading →

MedShadow Receives Spring 2016 Digital Health Award for Its Website

June 13, 2016, New York, NY – MedShadow has been recognized with a Spring 2016 Digital Health Awards Silver designation for its website in the Nonprofit category. Winners were announced on June 10th.  Formerly known as the Web Health Awards, the Digital Health Awards are held twice each year – Continue Reading →

Prince’s Fentanyl Overdose & Public Misconceptions About Opioids

“There’s a straight line between the overprescribing of opioids, the public’s misconceptions about these drugs and the rapidly rising number of accidental deaths from opioid addiction.”

MedShadow Foundation Welcomes New Content Editor, Jonathan Block

Online health advocacy source broadens coverage of side effects, risks and benefits of medicine

NEW YORK, NY, April 28th, 2016 – MedShadow Foundation, an online nonprofit that educates consumers on the side effects, risks and benefits of medicine, has announced the appointment of Jonathan Block as Content Editor.

“We Continue Reading →

More Press Releases →

Media Appearances:

The Story Exchange: Informing the Public on Drug Risks & Benefits

Featured as part of The Story Exchange’s 1000+ Stories campaign dedicated to telling the personal and professional stories of women business owners — and to exploring the role of entrepreneurship in advancing women’s economic independence. Read Suzanne Robotti’s story here.

Medscape Medical News: FDA Panels Say Risks of Opana ER Outweigh Benefits

A panel of US Food and Drug Administration (FDA) experts has advised the agency that the risks of an abuse-deterrent extended-release formulation of oxymorphone (Opana ER, Endo Pharmaceuticals) for relief of severe pain now outweigh its benefits. Read here.

Radio MD: Sexy Foods For Boosting Your Libido

Medications that assist with sexual function have become available over the past few decades. Before you reach for that sex pill, be sure you’ve discussed the side effects in depth with your doctor. You wouldn’t want any undesirable effects to negatively impact your libido. Also, consider some natural ways to Continue Reading →

Everyday Health: Why I Talked My Husband Out of Taking Statins

Statins are so universally popular with doctors that I’ve heard one claim “they” should put “statins in the drinking water.” Statins lower cholesterol which is a good thing because high cholesterol can lead to a heart attack or a stroke. Heart attacks are the No. 1 killer in the US Continue Reading →